Mml Investors Services, LLC Immuno Gen, Inc. Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $25,680 - $61,726	-2,061 Reduced 14.28%	12,376 $367,000
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $33,139 - $46,734	2,352 Added 19.46%	14,437 $229,000
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $1,005 - $5,373	-268 Reduced 2.17%	12,085 $228,000
Q1 2023 May 12, 2023	SELL	$3.67 - $4.92 $499 - $669	-136 Reduced 1.09%	12,353 $47,000
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $12,198 - $16,917	-2,681 Reduced 17.67%	12,489 $62,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $8,225 - $11,878	-1,836 Reduced 10.8%	15,170 $73,000
Q2 2022 Aug 12, 2022	BUY	$3.15 - $5.76 $941 - $1,722	299 Added 1.79%	17,006 $77,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $5,018 - $8,811	1,178 Added 7.59%	16,707 $80,000
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $1,596 - $2,520	336 Added 2.21%	15,529 $115,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $3,077 - $4,039	613 Added 4.2%	15,193 $86,000
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $1,916 - $2,846	331 Added 2.32%	14,580 $96,000
Q1 2021 May 14, 2021	BUY	$6.5 - $10.53 $16,360 - $26,504	2,517 Added 21.45%	14,249 $115,000
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $614 - $1,271	-166 Reduced 1.4%	11,732 $76,000
Q3 2020 Nov 13, 2020	BUY	$3.45 - $4.89 $1,459 - $2,068	423 Added 3.69%	11,898 $43,000
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $3,701 - $5,954	-1,115 Reduced 8.86%	11,475 $52,000
Q1 2020 May 14, 2020	SELL	$2.12 - $6.8 $718 - $2,305	-339 Reduced 2.62%	12,590 $42,000
Q4 2019 Feb 11, 2020	SELL	$2.25 - $5.8 $18,900 - $48,720	-8,400 Reduced 39.38%	12,929 $66,000
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $18,290 - $27,930	-8,239 Reduced 27.86%	21,329 $52,000
Q2 2019 Aug 13, 2019	BUY	$1.8 - $3.3 $7,261 - $13,312	4,034 Added 15.8%	29,568 $64,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $6,410 - $15,720	2,660 Added 11.63%	25,534 $69,000
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $36,070 - $88,803	9,155 Added 66.73%	22,874 $110,000
Q3 2018 Nov 07, 2018	BUY	$8.6 - $11.26 $117,983 - $154,475	13,719 New	13,719 $130,000
Q1 2018 May 11, 2018	SELL	$6.7 - $12.95 $318,189 - $615,008	-47,491 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $94,555 - $147,708	18,650 Added 64.66%	47,491 $304,000
Q3 2017 Nov 14, 2017	BUY	$5.4 - $8.47 $155,741 - $244,283	28,841	28,841 $221,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account